Latest Vaccine Stories
CLEVELAND, May 10, 2012 /PRNewswire/ -- What makes a Grand Challenge grand? Consider the complexities of curing breast cancer, purging greenhouse gases from the atmosphere, launching civilian spacecraft, or eradicating the devastating AIDS pandemic. These are the kinds of problems that require an amplified approach to open innovation, or "connecting with the world" to find new solutions. Combining this approach with public messaging, marketing and social networking is the hallmark...
QUEBEC CITY, May 10, 2012 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Mr. Mike Wanner, Executive Vice President, Operations, will be presenting at the 13th Annual BioEquity Europe Conference. The conference is being held May 15-16, 2012, at the Frankfurt Marriott Hotel in Frankfurt, Germany. ...
GAITHERSBURG, Md., May 10, 2012 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the first quarter ended March 31, 2012. GenVec reported a net loss of $3.2 million, or $0.25 per share, compared with a net loss of $2.2 million, or $0.17 per share, in the comparable quarter of 2011. First Quarter and Recent Business Highlights Hearing Loss and Balance Disorders Program GenVec extended its Research Collaboration and License Agreement with Novartis....
BETHESDA, Md., May 4, 2012 /PRNewswire-USNewswire/ -- The National Foundation for Infectious Diseases will host the 15th Annual Conference on Vaccine Research, May 7-9, 2012, at the Hyatt Regency Inner Harbor in Baltimore, MD. This three-day conference presents high-quality, current reports of scientific progress via invited presentations and submitted abstracts. As the premier venue for cutting edge learning, effective data sharing, and scientific collaboration on issues related...
Recent Whooping Cough Epidemic Warrants Need for Concern SEATTLE, May 3, 2012 /PRNewswire-USNewswire/ -- In the past couple of months, Washington state has made national news with an epidemic of whooping cough and ongoing attention to measles outbreaks across the county--two deadly diseases that vaccines can prevent. The Washington State Medical Association (WSMA) is urging adults to make sure they are current on their immunizations and get the needed booster shots to keep their...
LANCASTER, Pa. and ROCKVILLE, Md., May 3, 2012 /PRNewswire/ -- Immunomic Therapeutics, Inc., ("ITI," Lancaster, PA) a privately-held biotechnology company with laboratories in Rockville, MD, announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug Application ("IND") filed for the allergy immunotherapy, JRC- LAMP-vax((TM)). On April 12th, the FDA notified ITI that there will be no clinical hold and that ITI may now...
HOUSTON, May 3, 2012 /PRNewswire-USNewswire/ -- Meningitis Angels (MA) a national organization founded in memory of Ryan Milley the only child of Bob and Frankie Milley (Milley) announced today the launch of a national contest that would have tweens and teens ages 10-18 submit a photo of themselves getting their meningitis shot. A complete set of rules for entry may be found at http://www.meningitis-angels.org/meningitis-angels-vaccination-poster-contest.html. "We hope this contest...
GAITHERSBURG, Md., May 3, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the first quarter ended March 31, 2012 on Thursday, May 10, 2012, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the Company's first quarter financial results and business outlook. To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980...
GAITHERSBURG, Md., May 3, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program. The SBIR grant, valued at approximately $590,000, will provide funding to further understand the impact of maternal...
No Further Extensions will be Granted HARRISBURG, Pa., April 27, 2012 /PRNewswire-USNewswire/ -- The Pennsylvania Department of Health is extending the grace period by two weeks for students to comply with new school immunization requirements. The new rules went into effect last August, and if students don't have the required immunizations, they may not be able to attend school. Families were given an eight-month provisional period when the school year began to get students up to...
Latest Vaccine Reference Libraries
Yellow fever is an acute viral hemorrhagic disease with a 40 to 50 nm enveloped RNA virus with positive sense of the Flaviviridae family. It is transmitted by the bite of female mosquitoes and is found in tropical and subtropical areas in South America and Africa, but not in Asia. Primates and a few kinds of mosquitoes are the only known hosts. The origin of the disease is most likely Africa. From there it was introduced to South America through the slave trade in the 16th century. There...
A virus is a small infectious agent that replicates inside the living cells of organisms. It is a small infectious agent that can replicate only inside the living cells of organisms. Most are too small to be seen by anything but a microscope and they infect all organisms from animals to plants to bacteria. The first one discovered was the tobacco virus in 1898. Since then around 5,000 viruses have been described in detail although there are millions of different types. They are found in...
Foot-and-mouth disease, FMD, is sometimes fatal and is highly contagious for cloven-hoofed animals. Along with hooved animals hedgehogs and elephants are susceptible to the disease as well. Llama and alpaca can develop mild symptoms but are resistant to the disease and don't pass it to other species. Mice, rats, and chickens have been infected artificially in a lab but it is not believed they can contract the disease under natural conditions. Humans can spread the disease by carrying the...
